GENEXTRA
Site Map | Disclaimer
About us | Milestone | Team | Scientific advisors
Strategy | How we work
Intercept | DAC | Congenia | Tethis
Press relases | In the news | Downloads
How to reach us
  • jul 10
    6
    Atlante Ventures acquires interest in Tethis (Genextra Group)
  • jan 10
    25
    Intercept Pharmaceuticals Raises $25 Million Series B Financing
  • jan 09
    14
    Tethis establishes a collaborative agreement with Cogentech ...
  • dec 09
    14
    Genextra S.p.A. raises over € 36 million in equity financing
  • oct 09
    27
    Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as ...
  • jul 08
    29
    Genextra completes $25 million financing to support completion of Intercept Pharmaceuticals’...
more news...
Please Downloads our:

- Corporate fact sheet 2010   (72KB)
reserved area
  • Intercept pharmaceuticals read more...
  • CONGENIA read more...
  • DAC read more...
  • TETHIS read more...
© Genextra S.p.A. Via Privata Giovannino De Grassi, 11 20123 Milano Italy Tel: +39 02 36515110 FAX: +39 02 36515115 P.IVA 04065780969